Spots Global Cancer Trial Database for ards
Every month we try and update this database with for ards cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components | NCT02549222 | Transfusion Rel... | Standard of Car... | - | Cerus Corporation | |
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies | NCT02804945 | Blood And Marro... Adult Respirato... | Mesenchymal Ste... | 18 Years - | M.D. Anderson Cancer Center | |
Stellate Ganglion Blockade in COVID-19 Positive Patients | NCT04445337 | COVID 19 ARDS | Stellate Gangli... | 19 Years - 85 Years | University of Nebraska |